LANXESS Q2 Jumped 6%-But the €450M to €550M EBITDA Test Starts Now

Q2 improvement is real, but full-year recovery still needs proof

LANXESS delivered a +6% Q2 sales rebound, which is a constructive sign. The problem is that one strong quarter does not undo the damage from a year when revenue was down 10.9 percent and EBITDA pre exceptionals fell to EUR 510 million.

Why the full-year EBITDA range matters more than the Q2 headline

The key question is whether this rebound is the start of a trend or just a one-quarter catch-up. LANXESS is still guiding to EUR 450 and 550 million in full-year 2026 EBITDA pre exceptionals. If the second half improves as management expects, Q2 could prove to be an inflection point. If not, the stock remains anchored to the weak 2025 base case.

A reasonable bull case is that demand is finally stabilizing and management still has the 2026 target in view. A reasonable bear case is that one quarter does not fix weak demand, lower volumes, and pricing pressure across the business.

Watch three things next: - Whether sales growth broadens beyond a single quarter - Whether EBITDA improves from the Q2 2025: 150 € million baseline and holds up - Whether management continues to support its full-year EBITda target as more quarters are added in

Sequential improvement is the clearest positive signal

The market's main question is not whether LANXESS improved in Q2. It is whether the improvement is durable enough to change the full-year story.

What got better in Q2

The clearest signal is sequential. LANXESS reported a 13% sequential sales rise, a 62% sequential EBITDA increase, and improvement across all three segments. Management also cited higher volumes, pricing, and Middle East-related demand, while noting that free cash flow turned clearly positive.

Management also maintained its outlook for the next quarter, telling investors it still expects third-quarter EBITDA of €130 million to €150 million despite economic uncertainty, foreign-exchange headwinds, and logistics pressure. That does not guarantee a stronger half, but it does suggest management sees at least some follow-through.

Why investors still need more confirmation

The caution is understandable. LANXESS posted a Q2 2025: 10.2% margin in the quarter, but that still needs to be weighed against a 2025 full-year EBITDA margin of 9.0 percent after revenue was down 10.9 percent. Bulls can frame that as progress. Bears can fairly argue that margin quality still needs to be proven over a full cycle.

The operating backdrop also remains challenging. Low Rhine water levels have cut barge capacity to 20% to 30% of normal capacity, raising logistics costs, while management is also monitoring Asian competition. That makes the next few quarters important: investors need evidence that demand, not just cost control and pricing, is driving the recovery.

LANXESS looks constructive, but not yet convincing

After a +6% Q2 sales rebound and with management still backing third-quarter EBITDA of €130 million to €150 million, LANXESS looks more interesting than it did before the quarter. But it still looks more like a watchlist setup than a fully confirmed recovery.

The main test remains whether the company can deliver inside its current EUR 450 and 550 million 2026 EBITDA pre exceptionals range and then extend that improvement beyond a single quarter. Until that happens, the stock is better viewed as a proof-not-yet-confirmed setup than a clear rerating story.

What would confirm the setup

• A Q3 result at least in line with the guided €130 million to €150 million range
• Continued broad-based improvement across segments
• Evidence that logistics costs and currency headwinds do not erode the quarter-over-quarter gains

What would weaken the case

• A weaker-than-expected Q3
• Narrow recovery driven by one business or one pricing event
• Rising logistics or competitive pressures that start to outweigh demand improvement

Until official updates say otherwise, anchor on published company materials through lanxess.com/en/investors/reporting rather than on call summaries alone.